Kyntra Bio, Inc. (KYNB)
3.59
-0.09
(-2.45%)
USD |
NASDAQ |
Nov 12, 16:00
3.68
+0.09
(+2.51%)
After-Hours: 20:00
Kyntra Bio Market Cap : 14.54M for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 14.54M |
| November 11, 2026 | 14.90M |
| November 10, 2026 | 14.46M |
| November 09, 2026 | 15.79M |
| November 06, 2026 | 15.10M |
| November 05, 2026 | 14.82M |
| November 04, 2026 | 16.03M |
| November 03, 2026 | 17.45M |
| November 02, 2026 | 18.06M |
| October 30, 2026 | 18.50M |
| October 29, 2026 | 18.83M |
| October 28, 2026 | 19.11M |
| October 27, 2026 | 18.22M |
| October 26, 2026 | 18.22M |
| October 23, 2026 | 18.55M |
| October 22, 2026 | 21.14M |
| October 21, 2026 | 21.10M |
| October 20, 2026 | 21.38M |
| October 19, 2026 | 21.38M |
| October 16, 2026 | 19.64M |
| October 15, 2026 | 21.70M |
| October 14, 2026 | 22.53M |
| October 13, 2026 | 23.77M |
| October 12, 2026 | 24.78M |
| October 09, 2026 | 24.74M |
| Date | Value |
|---|---|
| October 08, 2026 | 24.13M |
| October 07, 2026 | 24.82M |
| October 06, 2026 | 24.13M |
| October 05, 2026 | 24.66M |
| October 02, 2026 | 25.55M |
| October 01, 2026 | 26.32M |
| September 30, 2026 | 26.93M |
| September 29, 2026 | 27.49M |
| September 28, 2026 | 27.94M |
| September 25, 2026 | 28.10M |
| September 24, 2026 | 28.34M |
| September 23, 2026 | 29.36M |
| September 22, 2026 | 29.48M |
| September 21, 2026 | 29.15M |
| September 18, 2026 | 28.65M |
| September 17, 2026 | 28.75M |
| September 16, 2026 | 30.81M |
| September 15, 2026 | 31.46M |
| September 14, 2026 | 32.51M |
| September 11, 2026 | 32.27M |
| September 10, 2026 | 32.29M |
| September 09, 2026 | 32.55M |
| September 08, 2026 | 33.28M |
| September 04, 2026 | 34.62M |
| September 03, 2026 | 34.38M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nektar Therapeutics | 1.271B |
| Capricor Therapeutics, Inc. | 595.34M |
| ARS Pharmaceuticals, Inc. | 381.95M |
| ACADIA Pharmaceuticals, Inc. | 3.134B |
| Alnylam Pharmaceuticals, Inc. | 20.97B |
Market Cap Related Metrics
| PE Ratio | 0.1111 |
| PS Ratio | 3.146 |
| Price | 3.59 |
| Earnings Yield | 899.9% |
| Normalized PE Ratio | 0.1073 |